{"code":"MMM","name":"Medicare/Medicaid","totalSpending":1170214506.3600001,"totalFilings":41218,"yearlySpending":[{"year":2018,"income":137657950.05,"filings":5189},{"year":2019,"income":145891244.54,"filings":5304},{"year":2020,"income":163887153.70999998,"filings":6005},{"year":2021,"income":171745046.63,"filings":5991},{"year":2022,"income":190284389,"filings":6441},{"year":2024,"income":162308775.23,"filings":5731},{"year":2025,"income":198439947.20000002,"filings":6557}],"topClients":[{"name":"AMERICAN HEALTH CARE ASSOCIATION","income":10167125},{"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","income":9492500},{"name":"PHRMA","income":8582050},{"name":"AMERICAN HOSPITAL ASSOCIATION","income":8152000},{"name":"AIR EVAC LIFETEAM","income":7110000},{"name":"GILEAD SCIENCES, INC.","income":6745000},{"name":"OMEROS CORPORATION","income":6635000},{"name":"GENENTECH","income":6090000},{"name":"NOVO NORDISK INC.","income":5480000},{"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)","income":5368250},{"name":"BLUE CROSS BLUE SHIELD ASSOCIATION","income":5330000},{"name":"GENENTECH, INC.","income":5150000},{"name":"AMERICAN MEDICAL ASSOCIATION","income":5060000},{"name":"FRESENIUS MEDICAL CARE NORTH AMERICA","income":4905000},{"name":"AMERICA'S HEALTH INSURANCE PLANS (AHIP)","income":4880000},{"name":"ELI LILLY AND COMPANY","income":4820000},{"name":"AMGEN","income":4790000},{"name":"CIGNA CORPORATION","income":4392250},{"name":"CENTENE CORPORATION","income":4279000},{"name":"EMD SERONO, INC.","income":4220000},{"name":"UNITEDHEALTH GROUP, INC.","income":4210000},{"name":"ASSURED GUARANTY MUNICIPAL CORP.","income":4180000},{"name":"AMGEN INC","income":4165000},{"name":"VERTEX PHARMACEUTICALS INCORPORATED","income":3985000},{"name":"ALLIANCE FOR CONNECTED CARE","income":3935000},{"name":"AMGEN INC.","income":3910000},{"name":"SERVICE EMPLOYEES INTERNATIONAL UNION","income":3890000},{"name":"BIOTECHNOLOGY INDUSTRY ORGANIZATION","income":3650000},{"name":"PARTNERSHIP FOR QUALITY HOME HEALTHCARE","income":3640000},{"name":"SELECT MEDICAL CORPORATION","income":3640000},{"name":"GRAIL, INC.","income":3590000},{"name":"ALNYLAM PHARMACEUTICALS, INC.","income":3560000},{"name":"KIDNEY CARE PARTNERS","income":3435000},{"name":"ASTRAZENECA","income":3410000},{"name":"TAKEDA PHARMACEUTICALS AMERICA, INC.","income":3320000},{"name":"AMGEN, INC.","income":3240000},{"name":"ALKERMES, INC.","income":3190000},{"name":"AMERICAN AMBULANCE ASSOCIATION","income":3183000},{"name":"NATIONAL ASSOCIATION OF SPECIALTY PHARMACY","income":3080000},{"name":"SENIOR CARE PHARMACY COALITION","income":3080000},{"name":"UNITEDHEALTH GROUP","income":3030000},{"name":"NOVARTIS","income":2995000},{"name":"HCA","income":2900000},{"name":"NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS","income":2900000},{"name":"JOHNSON & JOHNSON SERVICES, INC.","income":2850000},{"name":"SCAN HEALTH PLAN","income":2841500},{"name":"SAREPTA THERAPEUTICS","income":2840000},{"name":"UNIVERSITY OF PITTSBURGH MEDICAL CENTER","income":2830000},{"name":"HUMANA","income":2800000},{"name":"ASTELLAS PHARMA US, INC.","income":2790000}],"topFirms":[{"name":"TARPLIN, DOWNS & YOUNG, LLC","income":77500000},{"name":"MEHLMAN CONSULTING, INC.","income":41400000},{"name":"TIBER CREEK GROUP","income":34000000},{"name":"ALSTON & BIRD LLP","income":32555000},{"name":"CAPITOL COUNSEL LLC","income":31690000},{"name":"AKIN GUMP STRAUSS HAUER & FELD","income":30555000},{"name":"FORBES-TATE","income":28190000},{"name":"TODD STRATEGY GROUP","income":27230000},{"name":"AVENUE SOLUTIONS","income":26500000},{"name":"THE MCMANUS GROUP","income":26390000},{"name":"THE NICKLES GROUP, LLC","income":25229997},{"name":"WILLIAMS AND JENSEN, PLLC","income":23740000},{"name":"THORN RUN PARTNERS","income":22500000},{"name":"MCDERMOTT+ LLC","income":17775000},{"name":"CAPITOL HILL CONSULTING GROUP","income":15710000},{"name":"LIBERTY PARTNERS GROUP, LLC","income":15657000},{"name":"RED+BLUE STRATEGIES","income":15345000},{"name":"NVG, LLC","income":15220000},{"name":"FARRAGUT PARTNERS LLP","income":14847500},{"name":"JEFFREY J. KIMBELL & ASSOCIATES, INC.","income":13902000},{"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","income":13700000},{"name":"W STRATEGIES, LLC","income":12940000},{"name":"SPLITOAK STRATEGIES LLC","income":12830000},{"name":"STRATEGIC HEALTH CARE","income":11560900},{"name":"WELSH ROSE, LLC","income":11415000},{"name":"ARNOLD & PORTER KAYE SCHOLER LLP","income":11190000},{"name":"ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)","income":11140000},{"name":"KING & SPALDING LLP","income":10370000},{"name":"CROSSROADS STRATEGIES, LLC","income":10350000},{"name":"HEALTH POLICY SOURCE, INC.","income":10332000}],"sampleDescriptions":["Medicare physician payment and policy issues relating to cardiovascular and endovascular issues","allowing growth for hospitals with physician ownership","drug pricing, drug supply chain, opioid abuse epidemic, Medicare Part D","Dialysis vascular access services under Medicare","Funding opportunities for first responder products","Issues related to Medicare payment and reimbursement; provider nondiscrimination; scope of practice; and pain management issues.","Issues surrounding Medicare Dependent Hospitals\nPreserving Medicare reimbursement rates for rural public hospitals serving a disproportionate Medicare/Medcaid patient mix.","Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers","coverage and reimbursement, respiratory issues","Funding opportunities for first responder products.","Issues related to hospital and related provider reimbursement, outpatient hospital payment restrictions, disproportionate share hospitals, graduate medical education and delivery system reforms. Issue","Issues related to medicare and Medicaid reimbursement, issues related to rare diseases.","Health Care Reform; Medicare/Medicaid reimbursement issues","Hospital related issues; and medicare and medicaid issues.","H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017; S. 1914 - Protecting Access to Diabetes Supplies Act of 2017; Yet to be introduced House and Senate proposal for a regulatory fr","Institutions of Mental Disease (IMD) Exclusion","Issues related to payment and delivery reforms, Medicaid benefits and childrens hospital reimbursement. Issues related to pediatric research and childrens hospital graduate medical education.","Medicare and Medicaid reimbursement and funding issues, telemedicine and health care reform.","Medicare and Medicaid reimbursement and funding issues as well as health care reform.","Veterans administration (structure, benefits, services, and quality of care)   Family code (UCCJEA) Federal enforcement of parental rights. Veteran suicide epidemic (root causes, actions, programs, ac"]}